CLDX logo

Celldex Therapeutics (CLDX) Cost Of Goods Sold

Annual Cost Of Goods Sold

N/A

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

CLDX Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$12.08 M
CLDX annual cost of goods sold is currently at an all-time high

3-Year Low

-
CLDX annual cost of goods sold 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CLDX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 26, 2025
CLDX next annual earnings announcement is scheduled for Feb 26, 2025

OtherCLDXexpensesmetrics:

Annual Total Expenses

$148.93 M
CLDX annual total expenses is $148.93 million

Annual Operating Expenses

$148.93 M
CLDX annual total operating expenses is $148.93 million

Annual SGA

$30.91 M
CLDX annual SGA is $30.91 million

Annual D&A

$3.01 M
CLDX annual depreciation & amortization is $3.01 million

Quarterly Cost Of Goods Sold

N/A

September 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CLDX Quarterly Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.12 M
CLDX quarterly cost of goods sold is currently at an all-time high

3-Year Low

-
CLDX quarterly cost of goods sold 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CLDX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
CLDX next earnings announcement is scheduled for Feb 26, 2025

OtherCLDXexpensesmetrics:

Quarterly Total Expenses

$55.32 M
CLDX quarterly total expenses is $55.32 million

Quarterly Operating Expenses

$55.32 M
CLDX quarterly total operating expenses is $55.32 million

Quarterly SGA

$10.05 M
CLDX quarterly SGA is $10.05 million

Quarterly D&A

$786.00 K
CLDX quarterly depreciation & amortization is $786.00 thousand

TTM Cost Of Goods Sold

N/A

September 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CLDX TTM Cost Of Goods Sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$16.34 M
CLDX TTM cost of goods sold is currently at an all-time high

3-Year Low

-
CLDX TTM cost of goods sold 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CLDX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 26, 2025
CLDX next earnings announcement is scheduled for Feb 26, 2025

OtherCLDXexpensesmetrics:

Annual Total Expenses

$148.93 M
CLDX annual total expenses is $148.93 million

Annual Operating Expenses

$148.93 M
CLDX annual total operating expenses is $148.93 million

TTM SGA

-$5.80 B
CLDX TTM SGA is -$5.80 billion

TTM D&A

$3.12 M
CLDX TTM depreciation & amortization is $3.12 million

Cost Of Goods Sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

Annual Cost Of Goods Sold

-
CLDX annual cost of goods sold value is unknown

Annual Inventory

-
CLDX annual inventory value is unknown

CLDX Cost Of Goods Sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

CLDX Cost Of Goods Sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Celldex Therapeutics Cost Of Goods Sold History

DateAnnualQuarterlyTTM
Dec 2013
$2.33 M(-78.3%)
-
-
Mar 2013
-
$2.33 M(-34.3%)
$10.76 M(-0.1%)
Dec 2012
$10.78 M(+18.2%)
$3.55 M(+18.1%)
$10.77 M(-34.1%)
Sep 2012
-
$3.01 M(+60.5%)
$16.34 M(+22.5%)
Jun 2012
-
$1.87 M(-20.1%)
$13.34 M(-0.5%)
Mar 2012
-
$2.34 M(-74.3%)
$13.40 M(-1.2%)
Dec 2011
$9.12 M(-24.5%)
$9.12 M(+369.8%)
$13.56 M(+8.8%)
Jun 2011
-
$1.94 M(-22.4%)
$12.46 M(+1.7%)
Mar 2011
-
$2.50 M(-63.2%)
$12.25 M(+1.4%)
Dec 2010
$12.08 M(+43.8%)
$6.80 M(+458.3%)
$12.08 M(+50.9%)
Sep 2010
-
$1.22 M(-29.7%)
$8.01 M(-9.6%)
Jun 2010
-
$1.73 M(-25.6%)
$8.86 M(+4.3%)
Mar 2010
-
$2.33 M(-14.7%)
$8.50 M(+1.2%)
Dec 2009
$8.40 M(+126.3%)
$2.73 M(+31.7%)
$8.40 M(+48.1%)
Sep 2009
-
$2.07 M(+51.4%)
$5.67 M(+57.6%)
Jun 2009
-
$1.37 M(-38.6%)
$3.60 M(+61.4%)
Mar 2009
-
$2.23 M(-48.7%)
$2.23 M(-48.7%)
Dec 2008
$3.71 M(+8951.2%)
-
-
Mar 2006
-
$4.35 M(+7.9%)
$4.35 M(+7.9%)
Mar 2005
-
$4.03 M(>+9900.0%)
$4.03 M(+7787.7%)
Dec 2002
$41.00 K(+11.4%)
-
-
Sep 2002
-
$10.30 K(-39.4%)
$51.10 K(+3.9%)
Jun 2002
-
$17.00 K(+24.1%)
$49.20 K(+21.8%)
Mar 2002
-
$13.70 K(+35.6%)
$40.40 K(-108.0%)
Dec 2001
$36.80 K(-105.3%)
$10.10 K(+20.2%)
-$507.60 K(-27.4%)
Sep 2001
-
$8400.00(+2.4%)
-$699.10 K(-19.5%)
Jun 2001
-
$8200.00(-101.5%)
-$868.70 K(-16.3%)
Mar 2001
-
-$534.30 K(+194.5%)
-$1.04 M(+50.6%)
Dec 2000
-$689.30 K(-3.3%)
-$181.40 K(+12.5%)
-$689.30 K(+11.1%)
Sep 2000
-
-$161.20 K(-0.1%)
-$620.70 K(-18.3%)
Jun 2000
-
-$161.40 K(-12.9%)
-$759.50 K(+8.8%)
Mar 2000
-
-$185.30 K(+64.3%)
-$698.10 K(-2.1%)
Dec 1999
-$712.80 K(+78.2%)
-$112.80 K(-62.4%)
-$712.80 K(+18.8%)
Sep 1999
-
-$300.00 K(+200.0%)
-$600.00 K(+20.0%)
Jun 1999
-
-$100.00 K(-50.0%)
-$500.00 K(0.0%)
Mar 1999
-
-$200.00 K(0.0%)
-$500.00 K(+25.0%)
Dec 1998
-$400.00 K
-
-
Sep 1998
-
-$200.00 K(+100.0%)
-$400.00 K(+33.3%)
DateAnnualQuarterlyTTM
Jun 1998
-
-$100.00 K(0.0%)
-$300.00 K(0.0%)
Mar 1998
-
-$100.00 K(0.0%)
-$300.00 K(0.0%)
Dec 1997
-$300.00 K(+200.0%)
-
-
Sep 1997
-
-$100.00 K(0.0%)
-$300.00 K(-25.0%)
Jun 1997
-
-$100.00 K(0.0%)
-$400.00 K(0.0%)
Mar 1997
-
-$100.00 K(-50.0%)
-$400.00 K(-500.0%)
Dec 1996
-$100.00 K(-108.3%)
-
-
Sep 1996
-
-$200.00 K(+100.0%)
$100.00 K(-85.7%)
Jun 1996
-
-$100.00 K(-150.0%)
$700.00 K(-41.7%)
Mar 1996
-
$200.00 K(0.0%)
$1.20 M(-7.7%)
Dec 1995
$1.20 M(0.0%)
$200.00 K(-50.0%)
$1.30 M(-7.1%)
Sep 1995
-
$400.00 K(0.0%)
$1.40 M(+7.7%)
Jun 1995
-
$400.00 K(+33.3%)
$1.30 M(0.0%)
Mar 1995
-
$300.00 K(0.0%)
$1.30 M(0.0%)
Dec 1994
$1.20 M(-20.0%)
$300.00 K(0.0%)
$1.30 M(-13.3%)
Sep 1994
-
$300.00 K(-25.0%)
$1.50 M(0.0%)
Jun 1994
-
$400.00 K(+33.3%)
$1.50 M(+7.1%)
Mar 1994
-
$300.00 K(-40.0%)
$1.40 M(0.0%)
Dec 1993
$1.50 M(+150.0%)
$500.00 K(+66.7%)
$1.40 M(+55.6%)
Sep 1993
-
$300.00 K(0.0%)
$900.00 K(+28.6%)
Jun 1993
-
$300.00 K(0.0%)
$700.00 K(-12.5%)
Mar 1993
-
$300.00 K(+200.0%)
$800.00 K(-20.0%)
Dec 1992
$600.00 K(-45.5%)
-
-
Oct 1992
-
$100.00 K(-75.0%)
$1.00 M(-16.7%)
Jul 1992
-
$400.00 K(+100.0%)
$1.20 M(+9.1%)
Apr 1992
-
$200.00 K(-33.3%)
$1.10 M(-15.4%)
Apr 1992
$1.10 M(0.0%)
-
-
Jan 1992
-
$300.00 K(0.0%)
$1.30 M(0.0%)
Oct 1991
-
$300.00 K(0.0%)
$1.30 M(+8.3%)
Jul 1991
-
$300.00 K(-25.0%)
$1.20 M(0.0%)
Apr 1991
$1.10 M(+37.5%)
$400.00 K(+33.3%)
$1.20 M(+20.0%)
Jan 1991
-
$300.00 K(+50.0%)
$1.00 M(0.0%)
Oct 1990
-
$200.00 K(-33.3%)
$1.00 M(+25.0%)
Jul 1990
-
$300.00 K(+50.0%)
$800.00 K(+60.0%)
Apr 1990
$800.00 K(0.0%)
$200.00 K(-33.3%)
$500.00 K(+66.7%)
Jan 1990
-
$300.00 K
$300.00 K
Apr 1989
$800.00 K(+166.7%)
-
-
Apr 1988
$300.00 K(-400.0%)
-
-
Apr 1987
-$100.00 K
-
-

FAQ

  • What is the all time high annual cost of goods sold for Celldex Therapeutics?
  • What is the all time high quarterly cost of goods sold for Celldex Therapeutics?
  • What is the all time high TTM cost of goods sold for Celldex Therapeutics?

What is the all time high annual cost of goods sold for Celldex Therapeutics?

Celldex Therapeutics all-time high annual cost of goods sold is $12.08 M

What is the all time high quarterly cost of goods sold for Celldex Therapeutics?

Celldex Therapeutics all-time high quarterly cost of goods sold is $9.12 M

What is the all time high TTM cost of goods sold for Celldex Therapeutics?

Celldex Therapeutics all-time high TTM cost of goods sold is $16.34 M